Team Kendall's Social Media

  • Wix Facebook page
  • Instagram Social Icon

Chondrial Therapeutics LLC is developing a drug for Friedreich’s Ataxia

August 14, 2014

Doctors with Chondrial Therapeutics LLC are on the verge of a human trial to test a delivery method of a protein called frataxin, which is used by each cell’s power plants—called mitochondria—to convert fat and sugar into energy. Friedreich’s Ataxia (FA) patients’ cells do not produce enough frataxin, causing the central nervous system breakdown.


After teaming up with Ron Bartek, founder of the Friedreich’s Ataxia Research Alliance, the research is on track for Phase 1 of the trials to begin in 2016. To read more about Chondrial Therapeutics LLC and their work with FA, click here


Please reload

Featured Posts

What Fundraising Means to Me

March 7, 2019

Please reload

recent posts

January 5, 2020

December 18, 2019

December 12, 2019

December 6, 2019

November 26, 2019

November 22, 2019

November 18, 2019

October 17, 2019

Please reload